Year |
Citation |
Score |
2021 |
Shepard JD, Freitas BT, Rodriguez SE, Scholte FEM, Baker K, Hutchison MR, Longo JE, Miller HC, O'Boyle BM, Tandon A, Zhao P, Grimsey NJ, Wells L, Bergeron É, Pegan SD. The Structure and Immune Regulatory Implications of the Ubiquitin-Like Tandem Domain Within an Avian 2'-5' Oligoadenylate Synthetase-Like Protein. Frontiers in Immunology. 12: 794664. PMID 35058932 DOI: 10.3389/fimmu.2021.794664 |
0.301 |
|
2021 |
Durie IA, Dzimianski JV, Daczkowski CM, McGuire J, Faaberg K, Pegan SD. Structural insights into the interaction of papain-like protease 2 from the alphacoronavirus porcine epidemic diarrhea virus and ubiquitin. Acta Crystallographica. Section D, Structural Biology. 77: 943-953. PMID 34196620 DOI: 10.1107/S205979832100509X |
0.346 |
|
2020 |
Dzimianski JV, Mace SL, Williams IL, Freitas BT, Pegan SD. Flipping the substrate preference of Hazara virus ovarian tumour domain protease through structure-based mutagenesis. Acta Crystallographica. Section D, Structural Biology. 76: 1114-1123. PMID 33135682 DOI: 10.1107/S2059798320012875 |
0.409 |
|
2020 |
Freitas BT, Scholte FEM, Bergeron É, Pegan SD. How ISG15 combats viral infection. Virus Research. 198036. PMID 32492472 DOI: 10.1016/J.Virusres.2020.198036 |
0.37 |
|
2020 |
Freitas BT, Durie IA, Murray J, Longo JE, Miller HC, Crich D, Hogan RJ, Tripp RA, Pegan SD. Characterization and noncovalent inhibition of the deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease. Acs Infectious Diseases. PMID 32428392 DOI: 10.1021/Acsinfecdis.0C00168 |
0.382 |
|
2019 |
Dzimianski JV, Scholte FEM, Williams IL, Langley C, Freitas BT, Spengler JR, Bergeron É, Pegan SD. Determining the molecular drivers of species-specific interferon-stimulated gene product 15 interactions with nairovirus ovarian tumor domain proteases. Plos One. 14: e0226415. PMID 31869347 DOI: 10.2210/Pdb6Oar/Pdb |
0.438 |
|
2019 |
Scholte FEM, Hua BL, Spengler JR, Dzimianski JV, Coleman-McCray JD, Welch SR, McMullan LK, Nichol ST, Pegan SD, Spiropoulou CF, Bergeron É. Stable Occupancy of the Crimean-Congo Hemorrhagic Fever Virus-Encoded Deubiquitinase Blocks Viral Infection. Mbio. 10. PMID 31337717 DOI: 10.1128/Mbio.01065-19 |
0.4 |
|
2019 |
Bester SM, Adipietro KA, Funk VL, Myslinski J, Keul ND, Cheung J, Wilder PT, Wood ZA, Weber DJ, Height JJ, Pegan SD. The structural and biochemical impact of monomerizing human acetylcholinesterase. Protein Science : a Publication of the Protein Society. PMID 30993792 DOI: 10.1002/Pro.3625 |
0.426 |
|
2019 |
Dzimianski JV, Scholte FEM, Bergeron É, Pegan SD. ISG15: it's Complicated. Journal of Molecular Biology. PMID 30890331 DOI: 10.1016/J.Jmb.2019.03.013 |
0.39 |
|
2019 |
Langley C, Goodwin O, Dzimianski JV, Daczkowski CM, Pegan SD. Structure of interferon-stimulated gene product 15 (ISG15) from the bat species Myotis davidii and the impact of interdomain ISG15 interactions on viral protein engagement. Acta Crystallographica. Section D, Structural Biology. 75: 21-31. PMID 30644842 DOI: 10.1107/S2059798318015322 |
0.405 |
|
2019 |
Dzimianski JV, Beldon BS, Daczkowski CM, Goodwin OY, Scholte FEM, Bergeron É, Pegan SD. Probing the impact of nairovirus genomic diversity on viral ovarian tumor domain protease (vOTU) structure and deubiquitinase activity. Plos Pathogens. 15: e1007515. PMID 30629698 DOI: 10.1371/Journal.Ppat.1007515 |
0.507 |
|
2018 |
Bester SM, Guelta MA, Cheung J, Winemiller MD, Bae SY, Myslinski J, Pegan SD, Height JJ. Structural insights of stereospecific inhibition of human acetylcholinesterase by VX and subsequent reactivation by HI-6. Chemical Research in Toxicology. PMID 30462502 DOI: 10.1021/acs.chemrestox.8b00294 |
0.398 |
|
2018 |
Bester SM, Daczkowski CM, Faaberg KS, Pegan SD. Insights into PRRSV viral ovarian tumor domain protease specificity for ubiquitin and interferon-stimulated gene product 15. Acs Infectious Diseases. PMID 29856201 DOI: 10.1021/Acsinfecdis.8B00068 |
0.4 |
|
2017 |
Kim S, Alsaidan OA, Goodwin O, Li Q, Sulejmani E, Han Z, Bai A, Albers T, Beharry Z, Zheng YGG, Norris JS, Szulc ZM, Bielawska A, Lebedyeva I, Pegan SD, et al. Blocking myristoylation of Src inhibits its kinase activity and suppresses prostate cancer progression. Cancer Research. PMID 29038344 DOI: 10.1158/0008-5472.Can-17-0981 |
0.302 |
|
2017 |
Daczkowski CM, Goodwin O, Dzimianski JV, Farhat JJ, Pegan SD. Structurally guided removal of deISGylase biochemical activity from papain-Like protease originating from the Middle East Respiratory Syndrome Virus. Journal of Virology. PMID 28931677 DOI: 10.1128/Jvi.01067-17 |
0.44 |
|
2017 |
Scholte FEM, Zivcec M, Dzimianski JV, Deaton MK, Spengler JR, Welch SR, Nichol ST, Pegan SD, Spiropoulou CF, Bergeron É. Crimean-Congo Hemorrhagic Fever Virus Suppresses Innate Immune Responses via a Ubiquitin and ISG15 Specific Protease. Cell Reports. 20: 2396-2407. PMID 28877473 DOI: 10.1016/J.Celrep.2017.08.040 |
0.403 |
|
2017 |
Daczkowski CM, Dzimianski JV, Clasman JR, Goodwin O, Mesecar AD, Pegan SD. Structural insights into the interaction of coronavirus papain-like proteases and interferon-stimulated gene product 15 from different species. Journal of Molecular Biology. PMID 28438633 DOI: 10.1016/J.Jmb.2017.04.011 |
0.477 |
|
2016 |
Deaton MK, Dzimianski JV, Daczkowski CM, Whitney GK, Mank NJ, Parham MM, Bergeron E, Pegan SD. Biochemical and structural insights into nairoviral deISGylases preference for interferon-stimulated-gene-product 15 originating from certain species. Journal of Virology. PMID 27412597 DOI: 10.1128/Jvi.00975-16 |
0.437 |
|
2015 |
Zivcec M, Metcalfe MG, Albariño CG, Guerrero LW, Pegan SD, Spiropoulou CF, Bergeron É. Assessment of Inhibitors of Pathogenic Crimean-Congo Hemorrhagic Fever Virus Strains Using Virus-Like Particles. Plos Neglected Tropical Diseases. 9: e0004259. PMID 26625182 DOI: 10.1371/Journal.Pntd.0004259 |
0.322 |
|
2015 |
Daczkowski CM, Pegan SD, Harvey SP. Engineering the Organophosphorus Acid Anhydrolase Enzyme for Increased Catalytic Efficiency and Broadened Stereospecificity on Russian VX. Biochemistry. 54: 6423-33. PMID 26418828 DOI: 10.1021/Acs.Biochem.5B00624 |
0.417 |
|
2015 |
Eisenmesser EZ, Capodagli GC, Armstrong GS, Holliday MJ, Isern NG, Zhang F, Pegan SD. Inherent dynamics within the Crimean-Congo Hemorrhagic fever virus protease are localized to the same region as substrate interactions. Protein Science : a Publication of the Protein Society. 24: 651-60. PMID 25564798 DOI: 10.1002/Pro.2637 |
0.75 |
|
2014 |
Capodagli GC, Lee SA, Boehm KJ, Brady KM, Pegan SD. Structural and functional characterization of methicillin-resistant Staphylococcus aureus's class IIb fructose 1,6-bisphosphate aldolase. Biochemistry. 53: 7604-14. PMID 25390935 DOI: 10.1021/Bi501141T |
0.735 |
|
2014 |
Zhai X, Go MK, O'Donoghue AC, Amyes TL, Pegan SD, Wang Y, Loria JP, Mesecar AD, Richard JP. Enzyme architecture: the effect of replacement and deletion mutations of loop 6 on catalysis by triosephosphate isomerase. Biochemistry. 53: 3486-501. PMID 24825099 DOI: 10.1021/Bi500458T |
0.38 |
|
2014 |
Deaton MK, Spear A, Faaberg KS, Pegan SD. The vOTU domain of highly-pathogenic porcine reproductive and respiratory syndrome virus displays a differential substrate preference. Virology. 454: 247-53. PMID 24725951 DOI: 10.1016/J.Virol.2014.02.026 |
0.405 |
|
2014 |
Capodagli GC, Sedhom WG, Jackson M, Ahrendt KA, Pegan SD. A noncompetitive inhibitor for Mycobacterium tuberculosis's class IIa fructose 1,6-bisphosphate aldolase. Biochemistry. 53: 202-13. PMID 24325645 DOI: 10.1021/Bi401022B |
0.745 |
|
2013 |
Capodagli GC, Deaton MK, Baker EA, Lumpkin RJ, Pegan SD. Diversity of ubiquitin and ISG15 specificity among nairoviruses' viral ovarian tumor domain proteases. Journal of Virology. 87: 3815-27. PMID 23345508 DOI: 10.1128/Jvi.03252-12 |
0.757 |
|
2013 |
Pegan SD, Rukseree K, Capodagli GC, Baker EA, Krasnykh O, Franzblau SG, Mesecar AD. Active site loop dynamics of a class IIa fructose 1,6-bisphosphate aldolase from Mycobacterium tuberculosis. Biochemistry. 52: 912-25. PMID 23298222 DOI: 10.1021/Bi300928U |
0.758 |
|
2012 |
Ray SP, Deaton MK, Capodagli GC, Calkins LA, Sawle L, Ghosh K, Patterson D, Pegan SD. Structural and biochemical characterization of human adenylosuccinate lyase (ADSL) and the R303C ADSL deficiency-associated mutation. Biochemistry. 51: 6701-13. PMID 22812634 DOI: 10.1021/Bi300796Y |
0.718 |
|
2011 |
Connor SE, Capodagli GC, Deaton MK, Pegan SD. Structural and functional characterization of Mycobacterium tuberculosis triosephosphate isomerase. Acta Crystallographica. Section D, Biological Crystallography. 67: 1017-22. PMID 22120738 DOI: 10.1107/S0907444911042971 |
0.741 |
|
2011 |
Pegan SD, Sturdy M, Ferry G, Delagrange P, Boutin JA, Mesecar AD. X-ray structural studies of quinone reductase 2 nanomolar range inhibitors. Protein Science : a Publication of the Protein Society. 20: 1182-95. PMID 21538647 DOI: 10.1002/Pro.647 |
0.368 |
|
2011 |
Capodagli GC, McKercher MA, Baker EA, Masters EM, Brunzelle JS, Pegan SD. Structural analysis of a viral ovarian tumor domain protease from the Crimean-Congo hemorrhagic fever virus in complex with covalently bonded ubiquitin. Journal of Virology. 85: 3621-30. PMID 21228232 DOI: 10.1128/Jvi.02496-10 |
0.754 |
|
2010 |
Burks EA, Fleming CD, Mesecar AD, Whitman CP, Pegan SD. Kinetic and structural characterization of a heterohexamer 4-oxalocrotonate tautomerase from Chloroflexus aurantiacus J-10-fl: implications for functional and structural diversity in the tautomerase superfamily . Biochemistry. 49: 5016-27. PMID 20465238 DOI: 10.1021/Bi100502Z |
0.408 |
|
2009 |
Guo S, Tipparaju SK, Pegan SD, Wan B, Mo S, Orjala J, Mesecar AD, Franzblau SG, Kozikowski AP. Natural product leads for drug discovery: isolation, synthesis and biological evaluation of 6-cyano-5-methoxyindolo[2,3-a]carbazole based ligands as antibacterial agents. Bioorganic & Medicinal Chemistry. 17: 7126-30. PMID 19783449 DOI: 10.1016/J.Bmc.2009.08.061 |
0.357 |
|
2009 |
Maiti A, Reddy PV, Sturdy M, Marler L, Pegan SD, Mesecar AD, Pezzuto JM, Cushman M. Synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activities. Journal of Medicinal Chemistry. 52: 1873-84. PMID 19265439 DOI: 10.1021/Jm801335Z |
0.301 |
|
2009 |
Pegan SD, Rukseree K, Franzblau SG, Mesecar AD. Structural basis for catalysis of a tetrameric class IIa fructose 1,6-bisphosphate aldolase from Mycobacterium tuberculosis. Journal of Molecular Biology. 386: 1038-53. PMID 19167403 DOI: 10.1016/J.Jmb.2009.01.003 |
0.494 |
|
2008 |
Pegan SD, Serrano H, Whitman CP, Mesecar AD. Structural and mechanistic analysis of trans-3-chloroacrylic acid dehalogenase activity. Acta Crystallographica. Section D, Biological Crystallography. 64: 1277-82. PMID 19018104 DOI: 10.1107/S0907444908034707 |
0.436 |
|
2008 |
Ratia K, Pegan S, Takayama J, Sleeman K, Coughlin M, Baliji S, Chaudhuri R, Fu W, Prabhakar BS, Johnson ME, Baker SC, Ghosh AK, Mesecar AD. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proceedings of the National Academy of Sciences of the United States of America. 105: 16119-24. PMID 18852458 DOI: 10.1073/Pnas.0805240105 |
0.434 |
|
2008 |
Tipparaju SK, Joyasawal S, Forrester S, Mulhearn DC, Pegan S, Johnson ME, Mesecar AD, Kozikowski AP. Design and synthesis of 2-pyridones as novel inhibitors of the Bacillus anthracis enoyl-ACP reductase. Bioorganic & Medicinal Chemistry Letters. 18: 3565-9. PMID 18499454 DOI: 10.1016/J.Bmcl.2008.05.004 |
0.307 |
|
2007 |
Pegan S, Tan J, Huang A, Slesinger PA, Riek R, Choe S. NMR studies of interactions between C-terminal tail of Kir2.1 channel and PDZ1,2 domains of PSD95. Biochemistry. 46: 5315-22. PMID 17437338 DOI: 10.1021/Bi062228Q |
0.308 |
|
2006 |
Pegan S, Arrabit C, Slesinger PA, Choe S. Andersen's syndrome mutation effects on the structure and assembly of the cytoplasmic domains of Kir2.1. Biochemistry. 45: 8599-606. PMID 16834334 DOI: 10.1021/Bi060653D |
0.349 |
|
2005 |
Pegan S, Arrabit C, Zhou W, Kwiatkowski W, Collins A, Slesinger PA, Choe S. Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification. Nature Neuroscience. 8: 279-87. PMID 15723059 DOI: 10.1038/Nn1411 |
0.321 |
|
Low-probability matches (unlikely to be authored by this person) |
2011 |
Park SK, Pegan SD, Mesecar AD, Jungbauer LM, LaDu MJ, Liebman SW. Development and validation of a yeast high-throughput screen for inhibitors of Aβ₄₂ oligomerization. Disease Models & Mechanisms. 4: 822-31. PMID 21810907 DOI: 10.1242/Dmm.007963 |
0.293 |
|
2009 |
Mo S, Krunic A, Pegan SD, Franzblau SG, Orjala J. An antimicrobial guanidine-bearing sesterterpene from the cultured cyanobacterium Scytonema sp. Journal of Natural Products. 72: 2043-5. PMID 19888742 DOI: 10.1021/Np900288X |
0.289 |
|
2010 |
Yang JH, Kondratyuk TP, Marler LE, Qiu X, Choi Y, Cao H, Yu R, Sturdy M, Pegan S, Liu Y, Wang LQ, Mesecar AD, Van Breemen RB, Pezzuto JM, Fong HH, et al. Isolation and evaluation of kaempferol glycosides from the fern Neocheiropteris palmatopedata. Phytochemistry. 71: 641-7. PMID 20100622 DOI: 10.1016/J.Phytochem.2010.01.002 |
0.287 |
|
2019 |
Scott GK, Yau C, Becker BC, Khateeb S, Mahoney S, Borch Jensen M, Hann B, Cowen BJ, Pegan SD, Benz CC. Targeting mitochondrial proline dehydrogenase with a suicide inhibitor to exploit synthetic lethal interactions with p53 upregulation and glutaminase inhibition. Molecular Cancer Therapeutics. PMID 31189611 DOI: 10.1158/1535-7163.Mct-18-1323 |
0.279 |
|
2010 |
Pegan SD, Tian Y, Sershon V, Mesecar AD. A universal, fully automated high throughput screening assay for pyrophosphate and phosphate release from enzymatic reactions. Combinatorial Chemistry & High Throughput Screening. 13: 27-38. PMID 20201823 DOI: 10.2174/138620710790218203 |
0.279 |
|
2019 |
Hsu FL, Bae SY, McGuire J, Anderson DR, Bester SM, Height JJ, Pegan SD, Walz AJ. Synthesis and Molecular Properties of Nerve Agent Reactivator HLö-7 Dimethanesulfonate. Acs Medicinal Chemistry Letters. 10: 761-766. PMID 31097996 DOI: 10.1021/Acsmedchemlett.9B00021 |
0.254 |
|
2021 |
Reynolds ND, Aceves NM, Liu JL, Compton JR, Leary DH, Freitas BT, Pegan SD, Doctor KZ, Wu FY, Hu X, Legler PM. The SARS-CoV-2 SSHHPS Recognized by the Papain-like Protease. Acs Infectious Diseases. PMID 34019767 DOI: 10.1021/acsinfecdis.0c00866 |
0.253 |
|
2018 |
Alsaidan O, Kim S, Goodwin O, Li Q, Bai A, Bielawska A, Zheng G, Lebedyeva I, Albers T, Norris JS, Pegan SD, Cai H. Abstract A070: Targeting N-myristoyltransferase 1 inhibits prostate cancer progression Cancer Research. 78. DOI: 10.1158/1538-7445.Prca2017-A070 |
0.248 |
|
2020 |
Dhanju S, Upadhyaya K, Rice CA, Pegan SD, Media J, Valeriote FA, Crich D. Synthesis, Cytotoxicity and Genotoxicity of 10-Aza-9-oxakalkitoxin, An N,N,O-Trisubstituted Hydroxylamine Analog, or Hydroxalog, of a Marine Natural Product. Journal of the American Chemical Society. PMID 32364709 DOI: 10.1021/Jacs.0C03763 |
0.242 |
|
2003 |
Pegan S, Kwiatkowski W, Choe S, Riek R. High-throughput backbone resonance assignment of small 13C,15N-labeled proteins by a triple-resonance experiment with four sequential connectivity pathways using chemical shift-dependent, apparent 1J(1H,13C): HNCACBcodedHAHB. Journal of Magnetic Resonance (San Diego, Calif. : 1997). 165: 315-9. PMID 14643715 DOI: 10.1016/J.Jmr.2003.08.012 |
0.231 |
|
2023 |
Udompholkul P, Garza-Granados A, Alboreggia G, Baggio C, McGuire J, Pegan SD, Pellecchia M. Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist. Journal of Medicinal Chemistry. PMID 37262387 DOI: 10.1021/acs.jmedchem.3c00467 |
0.231 |
|
2008 |
Park S, Bagriantsev S, Callan LA, Pegan SD, Mesecar AD, Liebman SW. P2-350: Yeast cell-based genetic and chemical screens for inhibitors of Aβ42 oligomerization Alzheimer's & Dementia. 4: T475-T475. DOI: 10.1016/J.Jalz.2008.05.1427 |
0.229 |
|
2019 |
Scholte FEM, Spengler JR, Welch SR, Harmon JR, Coleman-McCray JD, Freitas BT, Kainulainen MH, Pegan SD, Nichol ST, Bergeron É, Spiropoulou CF. Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice. Emerging Microbes & Infections. 8: 575-578. PMID 30947619 DOI: 10.1080/22221751.2019.1601030 |
0.223 |
|
2022 |
Freitas BT, Ahiadorme DA, Bagul RS, Durie IA, Ghosh S, Hill J, Kramer NE, Murray J, O'Boyle BM, Onobun E, Pirrone MG, Shepard JD, Enos S, Subedi YP, Upadhyaya K, ... ... Pegan SD, et al. Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses. Acs Infectious Diseases. 8: 596-611. PMID 35199517 DOI: 10.1021/acsinfecdis.1c00631 |
0.219 |
|
2021 |
McGuire JR, Bester SM, Guelta MA, Cheung J, Langley C, Winemiller MD, Bae SY, Funk V, Myslinski JM, Pegan SD, Height JJ. Structural and Biochemical Insights into the Inhibition of Human Acetylcholinesterase by G-Series Nerve Agents and Subsequent Reactivation by HI-6. Chemical Research in Toxicology. PMID 33538594 DOI: 10.1021/acs.chemrestox.0c00406 |
0.216 |
|
2022 |
Durie IA, Tehrani ZR, Karaaslan E, Sorvillo TE, McGuire J, Golden JW, Welch SR, Kainulainen MH, Harmon JR, Mousa JJ, Gonzalez D, Enos S, Koksal I, Yilmaz G, Karakoc HN, ... ... Pegan SD, et al. Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus. Nature Communications. 13: 7298. PMID 36435827 DOI: 10.1038/s41467-022-34923-0 |
0.207 |
|
2021 |
Nejat R, Sadr AS, Freitas B, Crabttree J, Pegan SD, Tripp RA, Najafi D. Losartan Inhibits SARS-CoV-2 Replication in Vitro. Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society For Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques. 24: 390-399. PMID 34319871 DOI: 10.18433/jpps31931 |
0.207 |
|
2021 |
Wu Y, Pegan SD, Crich D, Desrochers E, Starling EB, Hansen MC, Booth C, Nicole Mullininx L, Lou L, Chang KY, Xie ZR. Polyphenols as alternative treatments of COVID-19. Computational and Structural Biotechnology Journal. 19: 5371-5380. PMID 34567475 DOI: 10.1016/j.csbj.2021.09.022 |
0.153 |
|
2021 |
Wu Y, Crich D, Pegan SD, Lou L, Hansen MC, Booth C, Desrochers E, Mullininx LN, Starling EB, Chang KY, Xie ZR. Polyphenols as Potential Inhibitors of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp). Molecules (Basel, Switzerland). 26. PMID 34946521 DOI: 10.3390/molecules26247438 |
0.141 |
|
2024 |
Garrison AR, Moresco V, Zeng X, Cline CR, Ward MD, Ricks KM, Olschner SP, Cazares LH, Karaaslan E, Fitzpatrick CJ, Bergeron É, Pegan SD, Golden JW. Nucleocapsid protein-specific monoclonal antibodies protect mice against Crimean-Congo hemorrhagic fever virus. Nature Communications. 15: 1722. PMID 38409240 DOI: 10.1038/s41467-024-46110-4 |
0.123 |
|
2023 |
Wu Y, Pegan SD, Crich D, Lou L, Mullininx LN, Starling EB, Booth C, Chishom AE, Chang KY, Xie ZR. Identifying Drug Candidates for COVID-19 with Large-Scale Drug Screening. International Journal of Molecular Sciences. 24. PMID 36901828 DOI: 10.3390/ijms24054397 |
0.12 |
|
Hide low-probability matches. |